Science & Enterprise subscription

Follow us on Twitter

  • Spark Therapeutics, a developer of gene therapies, is gaining access to a technology that programs DNA sequences li… https://t.co/WGboSsrf7U
    about 15 hours ago
  • New post on Science and Enterprise: Gene Therapy Company Exploring DNA Circuit Technology https://t.co/2YUM4DVZRK #Science #Business
    about 15 hours ago
  • A study with lab mice shows an experimental vaccine with engineered bacteria produces antibodies and protects again… https://t.co/3JtSqD1Sa2
    about 19 hours ago
  • New post on Science and Enterprise: Vaccine Stops Lyme Bacteria in Preclinical Test https://t.co/7H0Lc90nRe #Science #Business
    about 19 hours ago
  • Stop the panic porn ... Coronavirus Variants Don’t Have to Be Scary. Still, Mask Up. https://t.co/d6aDu2Ucj6
    about 22 hours ago

Please share Science & Enterprise

Infographic – Global Venture Funds Hit Record High

Global venture funds, Q1 2021

Venture investing, a key source of capital for research-based companies, hit a record high level worldwide in the first quarter of 2021. . . . → Read More: Infographic – Global Venture Funds Hit Record High

Infectious Disease Biotech Raises $100M in Venture Funds

Syringe and three vials

A biotechnology company designing vaccines for viral diseases including Covid-19 is raising $100 million in its second venture funding round. . . . → Read More: Infectious Disease Biotech Raises $100M in Venture Funds

Microsoft, Biotech Partner on Metastatic Cancer

Lung cancer illustration

A biotechnology start-up is collaborating with Microsoft Corp. on computational tools to find and predict factors that cause cancers to spread. . . . → Read More: Microsoft, Biotech Partner on Metastatic Cancer

Hearing Tech Company Raises New Venture Funds

Smart Ear device and app

A company creating devices that help people with hearing impairments, but without the stigma or cost of hearing aids, is raising $7 million in new venture funds. . . . → Read More: Hearing Tech Company Raises New Venture Funds

Cell-Based Fish Company Gains $8.25M in Seed Funds

Bluu Bioscience founders

The start-up enterprise Bluu Biosciences is underway creating seafood products from fish stem cells, and raising $US 8.25 million in seed funds. . . . → Read More: Cell-Based Fish Company Gains $8.25M in Seed Funds

Venture Fund to Support Seed-Stage Biotechs

KdT Ventures management

A venture capital company raised $50 million to invest in new businesses developing innovative products and services at the junction of biology and engineering. . . . → Read More: Venture Fund to Support Seed-Stage Biotechs

Precision Cancer Immunotherapy Biotech Underway

T-cells and cancer cells

A new company is beginning work on a safer form of cancer immunotherapy that avoids toxic off-target effects, and raising $55 million in venture funds. . . . → Read More: Precision Cancer Immunotherapy Biotech Underway

Infographic – Stanford, MIT Lead Start-Up Alma Maters

Chart: start-up founder universities

The founders of start-up tech companies in the U.S. raising $1 million or more since 1 Jan. 2020 come from mainly top research institutions. . . . → Read More: Infographic – Stanford, MIT Lead Start-Up Alma Maters

Vaccine Spin-Off Raises $168 Million in New Funds

Syringes

A developer of vaccines, including a leading Covid-19 vaccine, and cancer immunotherapies, is raising $168 million in its second venture round. . . . → Read More: Vaccine Spin-Off Raises $168 Million in New Funds

Venture Investor to Back Underserved Tech Entrepreneurs

Smartphones in business meeting

An investment company is offering training and seed funds to women technology entrepreneurs, and those in LGBTQ, racial, and ethnic minority communities. . . . → Read More: Venture Investor to Back Underserved Tech Entrepreneurs